Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients

Abstract This study evaluated the effectiveness of intraovarian platelet-rich plasma (PRP) injection in improving ovarian response and embryo quality in IVF patients with poor embryo quality in previous controlled ovarian hyperstimulation (COH) cycles. 74 patients participated, with 30 in the contro...

Full description

Saved in:
Bibliographic Details
Main Authors: Tzu-Ning Yu, Ming-Jer Chen, Tsung-Hsien Lee, Yi-Chun Chen, En-Hui Cheng, Chun-Chia Huang, Chung-I Chen, Chun-I Lee, Maw-Sheng Lee, Pin-Yao Lin
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-82630-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544781871710208
author Tzu-Ning Yu
Ming-Jer Chen
Tsung-Hsien Lee
Yi-Chun Chen
En-Hui Cheng
Chun-Chia Huang
Chung-I Chen
Chun-I Lee
Maw-Sheng Lee
Pin-Yao Lin
author_facet Tzu-Ning Yu
Ming-Jer Chen
Tsung-Hsien Lee
Yi-Chun Chen
En-Hui Cheng
Chun-Chia Huang
Chung-I Chen
Chun-I Lee
Maw-Sheng Lee
Pin-Yao Lin
author_sort Tzu-Ning Yu
collection DOAJ
description Abstract This study evaluated the effectiveness of intraovarian platelet-rich plasma (PRP) injection in improving ovarian response and embryo quality in IVF patients with poor embryo quality in previous controlled ovarian hyperstimulation (COH) cycles. 74 patients participated, with 30 in the control group and 44 in the PRP group. PRP was injected during the follicular phase for the PRP group. The control group completed two COH cycles, while the PRP group underwent COH cycles before and after the PRP injection. In the first COH cycle, there were no significant differences between groups. However, in the second COH cycle, the PRP group showed significant improvements: the number of fertilized oocytes increased (5.2 ± 3.6 vs. 3.3 ± 3.5, p = 0.011), total blastocysts (1.7 ± 1.5 vs. 0.5 ± 0.7, p < 0.0001) and good quality blastocysts (0.6 ± 0.8 vs. 0 ± 0.2, P < 0.0001). The total blastocyst rate (35 ± 31% vs. 13 ± 24%, p = 0.001) and good quality blastocyst rate (14 ± 22% vs. 1 ± 3%, p < 0.0001) were also higher in the PRP group. The most notable benefits occurred when COH was conducted one to two months post-PRP injection.
format Article
id doaj-art-d6cde18d1add480aa056311d96168b89
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-d6cde18d1add480aa056311d96168b892025-01-12T12:19:59ZengNature PortfolioScientific Reports2045-23222025-01-0115111010.1038/s41598-024-82630-1Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patientsTzu-Ning Yu0Ming-Jer Chen1Tsung-Hsien Lee2Yi-Chun Chen3En-Hui Cheng4Chun-Chia Huang5Chung-I Chen6Chun-I Lee7Maw-Sheng Lee8Pin-Yao Lin9Division of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalDivision of Infertility, Lee Women’s HospitalAbstract This study evaluated the effectiveness of intraovarian platelet-rich plasma (PRP) injection in improving ovarian response and embryo quality in IVF patients with poor embryo quality in previous controlled ovarian hyperstimulation (COH) cycles. 74 patients participated, with 30 in the control group and 44 in the PRP group. PRP was injected during the follicular phase for the PRP group. The control group completed two COH cycles, while the PRP group underwent COH cycles before and after the PRP injection. In the first COH cycle, there were no significant differences between groups. However, in the second COH cycle, the PRP group showed significant improvements: the number of fertilized oocytes increased (5.2 ± 3.6 vs. 3.3 ± 3.5, p = 0.011), total blastocysts (1.7 ± 1.5 vs. 0.5 ± 0.7, p < 0.0001) and good quality blastocysts (0.6 ± 0.8 vs. 0 ± 0.2, P < 0.0001). The total blastocyst rate (35 ± 31% vs. 13 ± 24%, p = 0.001) and good quality blastocyst rate (14 ± 22% vs. 1 ± 3%, p < 0.0001) were also higher in the PRP group. The most notable benefits occurred when COH was conducted one to two months post-PRP injection.https://doi.org/10.1038/s41598-024-82630-1PRP (platelet-rich plasma)COH (controlled ovarian stimulation)IVF (in vitro fertilization)Embryo qualityBlastocyst formation
spellingShingle Tzu-Ning Yu
Ming-Jer Chen
Tsung-Hsien Lee
Yi-Chun Chen
En-Hui Cheng
Chun-Chia Huang
Chung-I Chen
Chun-I Lee
Maw-Sheng Lee
Pin-Yao Lin
Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
Scientific Reports
PRP (platelet-rich plasma)
COH (controlled ovarian stimulation)
IVF (in vitro fertilization)
Embryo quality
Blastocyst formation
title Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
title_full Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
title_fullStr Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
title_full_unstemmed Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
title_short Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients
title_sort intraovarian platelet rich plasma injection significantly improves blastocyst yield and quality in ivf patients
topic PRP (platelet-rich plasma)
COH (controlled ovarian stimulation)
IVF (in vitro fertilization)
Embryo quality
Blastocyst formation
url https://doi.org/10.1038/s41598-024-82630-1
work_keys_str_mv AT tzuningyu intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT mingjerchen intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT tsunghsienlee intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT yichunchen intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT enhuicheng intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT chunchiahuang intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT chungichen intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT chunilee intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT mawshenglee intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients
AT pinyaolin intraovarianplateletrichplasmainjectionsignificantlyimprovesblastocystyieldandqualityinivfpatients